Overview

Study of Perifosine + Capecitabine for Colon Cancer Patients

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase I study of Perifosine + Capecitabine for patients with advanced colon cancer.
Phase:
Phase 1
Details
Lead Sponsor:
AEterna Zentaris
Collaborator:
SCRI Development Innovations, LLC
Treatments:
Capecitabine